These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1929 related articles for article (PubMed ID: 30038463)

  • 1. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
    To KK; Tong CW; Wu M; Cho WC
    World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma.
    Li X; Nie J; Mei Q; Han WD
    World J Gastroenterol; 2016 Jun; 22(23):5317-31. PubMed ID: 27340348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer.
    Miyoshi J; Toden S; Yoshida K; Toiyama Y; Alberts SR; Kusunoki M; Sinicrope FA; Goel A
    Sci Rep; 2017 Mar; 7():43393. PubMed ID: 28262692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs in colorectal cancer: role in metastasis and clinical perspectives.
    Muhammad S; Kaur K; Huang R; Zhang Q; Kaur P; Yazdani HO; Bilal MU; Zheng J; Zheng L; Wang XS
    World J Gastroenterol; 2014 Dec; 20(45):17011-9. PubMed ID: 25493013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular functions of microRNAs in colorectal cancer: recent roles in proliferation, angiogenesis, apoptosis, and chemoresistance.
    Ellakwa DE; Mushtaq N; Khan S; Jabbar A; Abdelmalek MA; Wadan AS; Ellakwa TE; Raza A
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Aug; 397(8):5617-5630. PubMed ID: 38619588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs as novel biomarkers for colorectal cancer: New outlooks.
    Shirafkan N; Mansoori B; Mohammadi A; Shomali N; Ghasbi M; Baradaran B
    Biomed Pharmacother; 2018 Jan; 97():1319-1330. PubMed ID: 29156521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The Role of MicroRNAs in Colorectal Cancer].
    Kim SW
    Korean J Gastroenterol; 2017 Apr; 69(4):206-211. PubMed ID: 28449421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers for Stratification in Colorectal Cancer: MicroRNAs.
    Fadaka AO; Pretorius A; Klein A
    Cancer Control; 2019; 26(1):1073274819862784. PubMed ID: 31431043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer.
    Stiegelbauer V; Perakis S; Deutsch A; Ling H; Gerger A; Pichler M
    World J Gastroenterol; 2014 Sep; 20(33):11727-35. PubMed ID: 25206276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential value of miR-1 and miR-374b as biomarkers for colorectal cancer.
    Wu X; Li S; Xu X; Wu S; Chen R; Jiang Q; Li Y; Xu Y
    Int J Clin Exp Pathol; 2015; 8(3):2840-51. PubMed ID: 26045793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum-based microRNA signature predicts relapse and therapeutic outcome of adjuvant chemotherapy in colorectal cancer patients.
    Ji D; Qiao M; Yao Y; Li M; Chen H; Dong Q; Jia J; Cui X; Li Z; Xia J; Gu J
    EBioMedicine; 2018 Sep; 35():189-197. PubMed ID: 30166271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on miRNAs as biological and clinical determinants in colorectal cancer: a bench-to-bedside approach.
    Weng W; Feng J; Qin H; Ma Y; Goel A
    Future Oncol; 2015; 11(12):1791-808. PubMed ID: 26075447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of miR-181c as a predictive marker of recurrence in stage II colorectal cancer.
    Yamazaki N; Koga Y; Taniguchi H; Kojima M; Kanemitsu Y; Saito N; Matsumura Y
    Oncotarget; 2017 Jan; 8(4):6970-6983. PubMed ID: 28036302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Dual Role of MicroRNAs in Colorectal Cancer Progression.
    Ding L; Lan Z; Xiong X; Ao H; Feng Y; Gu H; Yu M; Cui Q
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30227605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.
    Gao S; Tibiche C; Zou J; Zaman N; Trifiro M; O'Connor-McCourt M; Wang E
    JAMA Oncol; 2016 Jan; 2(1):37-45. PubMed ID: 26502222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging microRNA biomarkers for colorectal cancer diagnosis and prognosis.
    Chen B; Xia Z; Deng YN; Yang Y; Zhang P; Zhu H; Xu N; Liang S
    Open Biol; 2019 Jan; 9(1):180212. PubMed ID: 30958116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulated microRNAs in the colorectal cancer: diagnostic and therapeutic perspectives.
    Hernández R; Sánchez-Jiménez E; Melguizo C; Prados J; Rama AR
    BMB Rep; 2018 Nov; 51(11):563-571. PubMed ID: 30158023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer.
    Tsukamoto M; Iinuma H; Yagi T; Matsuda K; Hashiguchi Y
    Oncology; 2017; 92(6):360-370. PubMed ID: 28376502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs that regulate PTEN as potential biomarkers in colorectal cancer: a systematic review.
    Liu J; Ke F; Chen T; Zhou Q; Weng L; Tan J; Shen W; Li L; Zhou J; Xu C; Cheng H; Zhou J
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):809-820. PubMed ID: 32146564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [SIGNIFICANCE OF NONCODING RNAS IN COLORECTAL CANCER: REVIEW].
    Toiyama Y; Kusunoki M
    Nihon Geka Gakkai Zasshi; 2015 Nov; 116(6):360-5. PubMed ID: 26845887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 97.